{"id":205597,"date":"2026-06-16T16:18:19","date_gmt":"2026-06-16T16:18:19","guid":{"rendered":"https:\/\/www.europesays.com\/ee\/205597\/"},"modified":"2026-06-16T16:18:19","modified_gmt":"2026-06-16T16:18:19","slug":"uuring-%e2%9f%a9-tuntud-kaalulangetusravimid-pakuvad-kaitset-13-vahi-vastu","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ee\/205597\/","title":{"rendered":"UURING \u27e9 Tuntud kaalulangetusravimid pakuvad kaitset 13 v\u00e4hi vastu"},"content":{"rendered":"<p>GLP-1-ravimid, mida enamik seostab eelk\u00f5ige diabeediravi ja kaalulangetusega, on vaikselt t\u00f5usmas uueks tegijaks hoopis teises valdkonnas: v\u00e4hiennetuses. Ameerika teadlaste v\u00e4rske anal\u00fc\u00fcs viitab, et lisakilodega kimpus, kuid ilma diabeedita inimesed v\u00f5ivad nende s\u00fcstide abil p\u00e4\u00e4seda m\u00f5nest eriti salakavalast kasvaja\u00adt\u00fc\u00fcbist.<\/p>\n<p>Samas hoiatavad eksperdid liigse vaimustuse eest: vaatlusuuringul on omad piirangud ja k\u00fcsimusi on veel rohkem kui vastuseid. Mis t\u00e4pselt peitub nende populaarsete ravimite v\u00e4idetava v\u00e4hikaitse taga \u2013 ning kas nendest v\u00f5iksid kunagi saada ametlikud v\u00e4hi ennetusravimid?<\/p>\n","protected":false},"excerpt":{"rendered":"GLP-1-ravimid, mida enamik seostab eelk\u00f5ige diabeediravi ja kaalulangetusega, on vaikselt t\u00f5usmas uueks tegijaks hoopis teises valdkonnas: v\u00e4hiennetuses. Ameerika&hellip;\n","protected":false},"author":2,"featured_media":205598,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[80],"tags":[26,27,37,33,35,565,561,578,568,34,36,31,32,573,558,21,575,566,567,571,569,28,29,95,19,577,574,25,560,559,563,562,572,23,24,564,576,22,20,570,30,92,93,94],"class_list":["post-205597","post","type-post","status-publish","format-standard","has-post-thumbnail","category-maailm","tag-breaking-news","tag-breakingnews","tag-ee","tag-eesti","tag-eesti-keel","tag-emo","tag-ennetamine","tag-eriarst","tag-eriarsti-abi","tag-estonia","tag-estonian","tag-featured-news","tag-featurednews","tag-haigekassa","tag-haigus","tag-headlines","tag-itk","tag-kiirabi","tag-koduvisiit","tag-korvaltoime","tag-laste-haigused","tag-latest-news","tag-latestnews","tag-maailm","tag-news","tag-perearst","tag-perh","tag-populaarseimad-lood","tag-rahvameditsiin","tag-ravi","tag-tervise-arengu-instituut","tag-tervishoid","tag-toimeaine","tag-top-stories","tag-topstories","tag-trauma","tag-tu-kliinikum","tag-uldised-uudised","tag-uudised","tag-vaktsineerimine","tag-viimased-uudised","tag-world","tag-world-news","tag-worldnews"],"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/205597","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/comments?post=205597"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/205597\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media\/205598"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media?parent=205597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/categories?post=205597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/tags?post=205597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}